<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <billNumber>463</billNumber>
    <createDate>2017-03-01T05:20:57Z</createDate>
    <updateDate>2020-09-28T22:44:58Z</updateDate>
    <originChamber>Senate</originChamber>
    <billType>S</billType>
    <introducedDate>2017-02-28</introducedDate>
    <congress>115</congress>
    <recordedVotes />
    <committees>
      <billCommittees>
        <item>
          <systemCode>ssfi00</systemCode>
          <name>Finance Committee</name>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <subcommittees />
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-02-28T15:37:23Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <committeeReports />
    <relatedBills>
      <item>
        <latestTitle>Cancer Care Payment Reform Act of 2017</latestTitle>
        <congress>115</congress>
        <number>1834</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2017-04-12</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2017-02-28</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <links />
        <sourceSystem>
          <code>0</code>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1502-1504)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2017-02-28</actionDate>
        <links />
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees />
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <sponsors>
      <item>
        <bioguideId>C001056</bioguideId>
        <fullName>Sen. Cornyn, John [R-TX]</fullName>
        <firstName>John</firstName>
        <middleName />
        <lastName>Cornyn</lastName>
        <party>R</party>
        <state>TX</state>
        <identifiers>
          <lisID>1692</lisID>
          <bioguideId>C001056</bioguideId>
          <gpoId>8295</gpoId>
        </identifiers>
        <byRequestType />
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>C000174</bioguideId>
        <fullName>Sen. Carper, Thomas R. [D-DE]</fullName>
        <firstName>THOMAS</firstName>
        <middleName>R.</middleName>
        <lastName>CARPER</lastName>
        <party>D</party>
        <state>DE</state>
        <identifiers>
          <lisID>179</lisID>
          <bioguideId>C000174</bioguideId>
          <gpoId>8283</gpoId>
        </identifiers>
        <sponsorshipDate>2017-02-28</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <cboCostEstimates />
    <laws />
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Cancer</name>
          </item>
          <item>
            <name>Cardiovascular and respiratory health</name>
          </item>
          <item>
            <name>Digestive and metabolic diseases</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Emergency medical services and trauma care</name>
          </item>
          <item>
            <name>Health care quality</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Home and outpatient care</name>
          </item>
          <item>
            <name>Long-term, rehabilitative, and terminal care</name>
          </item>
          <item>
            <name>Medicare</name>
          </item>
          <item>
            <name>Performance measurement</name>
          </item>
          <item>
            <name>Women's health</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2017-02-28</actionDate>
          <actionDesc>Introduced in Senate</actionDesc>
          <lastSummaryUpdateDate>2017-04-10T13:50:04Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><strong>Cancer Care Payment Reform Act of 2017</strong></p> <p>This bill amends title XVIII (Medicare) of the Social Security Act to establish the Oncology Medical Home Demonstration Project, through which the Centers for Medicare &amp; Medicaid Services (CMS) shall make special payments to participating oncology practices that coordinate patient care and meet other specified requirements.</p> <p>During the first two years of the project, CMS shall pay a care coordination management fee to each such practice. After the third, fourth, and fifth years of the project, CMS shall pay a performance incentive payment to each participating practice that meets or exceeds performance standards developed by CMS.</p> <p>CMS shall assess the performance of each participating oncology practice annually. Performance standards shall address: (1) specified measures related to patient care, resource utilization, survivorship, and end-of-life care; and (2) the patient experience of care, as reflected in surveys submitted by each practice. CMS shall also assess the extent to which a practice has used breakthrough or other best-in-class therapies.</p> <p>To the extent practicable, CMS shall select practices of varying sizes and geographic areas for participation.</p>]]></text>
          <updateDate>2017-02-28T05:00:00Z</updateDate>
          <name>Introduced in Senate</name>
        </item>
      </billSummaries>
    </summaries>
    <title>Cancer Care Payment Reform Act of 2017</title>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>A bill to amend title XVIII of the Social Security Act to establish a national Oncology Medical Home Demonstration Project under the Medicare program for the purpose of changing the Medicare payment for cancer care in order to enhance the quality of care and to improve cost efficiency, and for other purposes.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Cancer Care Payment Reform Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Cancer Care Payment Reform Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Cancer Care Payment Reform Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <amendments />
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2017-02-28T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-115s463is/xml/BILLS-115s463is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2017-02-28</actionDate>
      <text>Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1502-1504)</text>
      <links />
    </latestAction>
    <calendarNumbers />
    <version>1.0.0</version>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

